Fundraising FoxAccelmed Partners
Private equityMiami · Pre-Seed–Late Stage · 10 people tracked
Also known as Accelmed · ACCELMED PARTNERS II MANAGEMENT, LLC
Find your way into Accelmed Partners
969 people in our graph share verified history with the Accelmed Partners team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Accelmed applies a private equity approach to healthcare technology, a sector traditionally served by venture and early-stage growth investors. The firm works closely with management teams to improve business operations, refresh product portfolios, and rebuild commercial organizations, supplying the resources and support portfolio companies need to grow. Its investment focus spans four areas: medical devices that help providers treat patients, tools and diagnostics that advance medical research and disease detection, digital health that improves the efficiency and precision of care delivery, and tech-enabled services that expand patient access through value-based delivery.
Source: firm website, verified Sep 29, 2026.
Team · 10 people
from the firm's website & public directories
Founder mafia
2 people who came through Accelmed Partners went on to found or lead other companies.
What they invest in
from 36 of 52 portfolio companiesHealthtech ×29Medical Devices ×27Digital Health ×12Biotech ×10Hardware ×7Robotics ×5FemTech ×3AI & Machine Learning ×2
HQs:United States×23Israel×3United Kingdom×1
Who they back
founder profiles across 15 portfolio companiesFounding team size:solo founder×72 founders×64+ founders×2
Where their founders studiedfrom 10 founders with education data
Tel Aviv University ×3Massachusetts Institute of Technology ×2
Where their founders worked beforefrom 11 founders with career history
Microsoft ×3MIT Media Lab ×3
Investments · 52 tracked
founders shown can be your intro pathBy year:2024 · 12023 · 12022 · 22021 · 22020 · 12019 · 12018 · 12015 · 12012 · 111 dated
NeuroPace is a commercial-stage medical device company that develops the RNS System, a brain-responsive neurostimulation platform delivering real-time treatment at the seizure source for patients with drug-resistant epilepsy and other brain disorders.
Digital HealthHardwareHealthtechMedical DevicesMountain View, US
Rebecca Kuhn(Executive Officer)inFrank Fischer(Executive Officer, Director)Joel Becker(President, Chief Executive Officer and Director)inVince Burgess(Director)inRenee Ryan(Director)inRay Larkin(Director)
Co-investorsNew Enterprise Associates (NEA)OrbiMed
Smith+Nephew is a medical technology company that develops products for the repair, regeneration, and replacement of soft and hard tissue, including sports medicine solutions for treating sporting injuries.
HealthtechMedical DevicesSports TechLondon, GB
Thomas James Smith(Founder)Horatio Nelson Smith(Co-founder)Deepak Nathin
Co-investorsAccess Venture PartnersAlphaDriveaMoonPeregrine VenturesTargeted Technology Funds
Click Therapeutics develops, validates, and commercializes software-based prescription medical treatments, including software-enhanced drug products that combine digital therapeutics with pharmacotherapy.
BiotechDigital HealthHealthtechMedical DevicesNew York, US
David B. Klein(Founder and CEO)inDavid Klein(Executive Officer, Director)inRandall Stanicky(Executive Officer)in
BoardAlex Zisson(Director)Lee Shapiro(Director)inCris De Luca(Director)in
Board seatUri Geiger· per SEC Form D
Co-investorsH.I.G. CapitalH.I.G. HealthBridge PartnersHealth Catalyst CapitalHikma VenturesRevelation PartnersSanofi Ventures+5 more
Developer of a transcatheter InterAtrial Shunt Device to treat congestive heart failure.
BiotechTewksbury, US
George J. Fazio(Executive Officer, Director)inDan B. Curtis(Executive Officer)
BoardPaul LaViolette(Director)inKevin Gillis(Director)inGerald Brunk(Director)inIrit Yaniv(Director)in
Board seatUri Geiger· per SEC Form D
Co-investorsLumira VenturesGeneral CatalystSV Health InvestorsThird Rock Ventures
.png)
EndoGastric Solutions offers the Transoral Incisionless Fundoplication (TIF 2.0) procedure and the EsophyX device used to treat GERD, along with reimbursement and technical/administrative support (TAP program) for medical practices.
BiotechHealthtechMedical DevicesSan Mateo, US
Philip Macdonald(Executive Officer)Louis Baldino(Executive Officer, Director)Lilip Lau(Executive Officer)Josh DeFonzo(Executive Officer)in
BoardMichael Carusi(Director)inArda Minocherhomjee(Director)
Board seatUri Geiger· per SEC Form D
Co-investorsCanaan PartnersEvidity Health CapitalLightstone VenturesVCFA GroupDe Novo VenturesFOUNDATION MEDICAL PARTNERS+1 more
MedMinder provides an integrated pharmacy, medication adherence, and connected care platform for healthcare providers, payors, and patients.
Digital HealthHardwareHealthtechMedical DevicesNorwood, US
TROY HILSENROTH(Executive Officer, Director)inEran Shavelsky(Executive Officer, Director)
BoardDANIEL COHEN(Director)inSundar Subramaniam(Director)Ben Dunn(Director)
Board seatUri Geiger· per SEC Form D
Strata Skin Sciences develops and provides dermatology treatment devices, including the XTRAC excimer laser and VTRAC excimer lamp for psoriasis and vitiligo, and the TheraClearX photopneumatic system for acne.
Advanced ManufacturingHardwareHealthtechMedical DevicesHorsham, US
Matthew Hill(CFO)Dolev Rafaeli(President & CEO)Samuel Rubinstein(Director)Samuel Navarro(Director)David Gill(Director)
Board seatUri Geiger· per SEC Form D
Acclaro develops UltraClear, an aesthetic laser platform using proprietary 2910 nm cold ablative fiber laser technology with seven treatment modules in one device for skin rejuvenation, addressing photodamage, wrinkles, acne scars, pigmentation, and laser-enabled surgical procedures.
HardwareMedical DevicesWellness & Fitness
AICure is an AI-powered medication adherence platform for life sciences organizations that uses computer vision and machine learning to verify patient medication adherence and capture real-time behavioral data to improve clinical trial outcomes and patient engagement.
AI & Machine LearningBiotechDigital HealthHealthtechMedical Devices
Sabina Chadha(Chief Executive Officer)inAnand Ramaswamy(Chief Product Officer)inJun Lu(VP of Engineering and AI)in
Co-investorsVIVE VCAsahi Kasei Corporate Venture CapitalPalisades Growth CapitalTribeca Venture PartnersBaird CapitalNew Leaf Venture Partners+3 more
Alpen Labs builds a Bitcoin layer-2 network that enables financial applications through a ZK rollup with optimistic bridge architecture.
Crypto & Web3FintechNew York City, US
Abishkar Chhetri(Chief Operating Officer)inPramod Kandel(Chief Technology Officer)inSimanta Gautam(Chief Executive Officer)inChandan Sharma Subedi(Co-Founder)inJohn LightinTrey Del Bonis
Co-investorsAsymmetricCastle Island VenturesHivemind Ventures, LlcLaunchpad CapitalMirana VenturesResolute Ventures+4 more
Cybersecurity asset management platform providing visibility and automated policy validation.
New York, US
Dean Sysman(Founder)inOfri Shur(Executive Officer, Director)inWendy Zheng(Executive Officer)in
BoardKenneth A. Fox(Director)Amit Karp(Director)Matt Weigand(Director)
Co-investorsAccelALIVE Israel HealthTech FundAlkeon InnovationAlphaDriveBessemer Venture PartnersBlue Owl Capital+10 more
Axora Medical develops minimally invasive hysteroscopy solutions for gynecologists to diagnose and treat intrauterine conditions such as polyps and fibroids in both office and operating room settings.
FemTechHealthtechMedical Devices
Moshe Geiger(Founder & Chairman)Darin Hammers(Chief Executive Officer)in
Bioness Medical develops neuromodulation systems, robotic systems, and software-based therapy programs for patients with central nervous system disorders and orthopedic injuries.
Digital HealthHealthtechMedical DevicesRobotics
Antonella Favit-Van Pelt(Chief Medical Officer)
Bioness Medical develops neuromodulation, robotic, and software-based medical technologies for patients with central nervous system disorders and orthopedic injuries.
BiotechDigital HealthMedical DevicesRobotics
Antonella Favit-Van Pelt(Chief Medical Officer)
Digma Medical develops the Endoscopic Gastrointestinal Ablation Device (EGAD), a minimally invasive therapy using a console and single-use catheter for contactless, imaging-guided ablation of esophageal mucosal tissue, initially targeting Barrett's Esophagus.
BiotechHealthtechMedical Devices
Co-investorsIncentive, Peregrine Ventures IncubatorPeregrine VenturesTal Ventures
Keenova is a specialty therapeutics company focused on rare, stigmatized, or unaddressed conditions across areas including immunology, urology, hepatology, ophthalmology, orthopedics, and critical care.
BiotechHealthtechMedical DevicesMalvern, US
Blaise Coleman(President; Chief Executive Officer)inMatthew Maletta(Executive Vice President; Chief Legal Officer; Secretary)inFrank Raciti(Vice President; Controller; Chief Accounting Officer)inMark Bradley(Executive Vice President; Chief Financial Officer)inScott Hirsch(Director)Paul Efron(Director)
Co-investorsSignet Healthcare Partners
Endospan develops endovascular stent graft systems, including the NEXUS Multi-Branch Aortic Arch Stent Graft System, for repairing aortic aneurysms and dissections in patients whose anatomy is unsuitable for traditional EVAR/TEVAR therapy.
HealthtechMedical Devices
Kevin Mayberry(Chief Executive Officer)inGadi Divald(Chief Financial Officer)
Co-investorsSCP Vitalife Partners
Medical device company with a single-use hybrid catheter for precise material removal; acquired by AngioDynamics in 2019.
Boston, US
Evan Witt(Executive Officer, Director)Josh Tayloe(Executive Officer)
Co-investorsIncentive, Peregrine Ventures IncubatorPeregrine VenturesTal Ventures
Zimmer Biomet is a medical device and digital health company committed to patient safety and product security across its portfolio.
Digital HealthHealthtechMedical DevicesRoboticsWarsaw, US
Co-investorsInnova Memphis, Inc.NaviMed CapitalInnova
GammaTile is an FDA-cleared, bioresorbable collagen tile embedded with radiation sources that is implanted during brain tumor removal surgery to deliver targeted radiation to remaining cancer cells.
BiotechHealthtechMedical Devices
David G. Brachman, MD, FASTRO(Co-Founder and Chief Technology Officer)Heyoung McBride, MD, MS, FASTRO(Co-Founder)Peter Nakaji, MD(Co-Founder)inEmad Youssef, MD(Co-Founder)Theresa Thomas, MS, CCRC(Co-Founder)Per Langoe(Chief Executive Officer)in
Co-investorsBlueStone Venture PartnersEvidity Health CapitalFemHealth VenturesGilde HealthcareMedTech Venture PartnersMVM Life Science Partners
GT Medical Technologies develops GammaTile, an implantable radiation therapy device for treating operable brain tumors.
BiotechHealthtechMedical Devices
Co-investorsBlueStone Venture PartnersEvidity Health CapitalFemHealth Ventures
Keystone Dental develops wide-diameter dental implant systems for molar replacement, engineered to provide primary stability and preserve bone structure.
E-commerceHealthtechMedical DevicesBurlington, US
Tony Susino(Chief Executive Officer)inErez Cohen(Chief Operating Officer)Amnon Tamir(Chief Financial Officer)
Momentis develops the Anovo Surgical System, a robotic surgery platform that supports a transvaginal, minimally-invasive approach with high articulation and reach.
HealthtechMedical DevicesRoboticsFort Lauderdale, US
Dvir Cohen(Co-founder & Chief Executive Officer)inNir Shvalb(Co-founder, Professor, PhD)in
Co-investorsKrillion Ventures
Minerva Labs was an Israeli endpoint security company whose anti-evasion platform prevented malware by simulating hostile environments to deter evasive threats.
Cybersecurity
Co-investorsAmplify PartnersLifeSci Venture PartnersSaints CapitalStageOne VenturesWebb Investment NetworkGlencrest Group
Momentis Surgical develops the Anovo Surgical System, a robotic platform designed for minimally-invasive surgery using a transvaginal approach with articulated instruments.
FemTechHealthtechMedical DevicesRoboticsOr Yehuda
Dvir Cohen(Chief Executive Officer)inNataly Fellous(Vice President Finance)inSteven Nunes(Chief Commercial Officer)inHagai Berkovich(Chief Operations Officer)Noam Atar(Chief Financial Officer)in
BoardMorry Blumenfeld(Director)
Co-investorsPeregrine Ventures
Nitinotes is an early-commercial-stage medical device company that makes EndoZip, an automated endoscopic suturing system for gastroplasty used to treat class I and II obesity in patients who do not qualify for traditional bariatric surgery.
HardwareHealthtechMedical DevicesCaesarea, IL
Co-investorsPeregrine Ventures
Nurx provides accessible and affordable medications and tests through a digital health platform designed for everyone.
Digital HealthDirect to ConsumerFemTechHealthtechWellness & FitnessNew York City, US
Edvard Engesaeth(Founder)Varsha Raoin
Co-investorsComcast VenturesDreamers VCFifty YearsForeground CapitalGarage CapitalKleiner Perkins+14 more
Pi-Cardia develops non-implant-based, catheter-delivered devices for treating structural heart disease, including its ShortCut product for leaflet modification.
HardwareHealthtechMedical Devices
Erez Golan(Founder)in
Co-investorsClal Biotechnology IndustriesIndaco Venture PartnersKreos CapitalSofinnova Partners
Proliferate is an open-source agent workspace that runs multiple AI coding agents (Claude Code, Codex, Gemini, and open models) in parallel on local or cloud infrastructure.
AI & Machine LearningDeveloper ToolsEnterprise SoftwareSaaSSan Francisco, US
Pablo Hansen(Founder)in
Co-investorsOutset CapitalPioneerY CombinatorAndreessen HorowitzAsylum VenturesCRV (Charles River Ventures)+9 more
Revamp Medical develops Doraya, a flow-reducing central venous catheter deployed in the infrarenal IVC to improve the efficacy of diuretic therapy in patients with acute heart failure.
HardwareHealthtechMedical DevicesNetanya, IL
Co-investorsArkin Capital
SeaSpine, a spine surgery products company, has become part of Orthofix.
Medical Devices
SKNV is a compounding pharmacy that supplies customized dermatological medications formulated without common inactive ingredients and allergens, serving dermatology providers and their patients across the U.S.
Digital HealthE-commerceHealthtech
Spencer Malkin(CEO & Co-Founder)in
TailorMed provides a platform that helps patients access, afford, and stay on their prescribed medications by connecting them to financial assistance and support programs.
Digital HealthHealthtechSaaS
Adam Siton(Founder)inIsrael (Srulik) Dvorsky(Founder)in
Co-investorsAllumia VenturesBallad VenturesBridges IsraelOSF VenturesSamsung NextSanara Capital+2 more
Valcare Medical develops transcatheter solutions for treating mitral regurgitation, a structural heart condition, aiming to provide surgical-level durability without open-heart surgery.
Deep TechHealthtechMedical DevicesWilmington, US
Steve Sandweg(Chief Executive Officer)inDr. David Meerkin(Chief Medical Officer)Nadav Yellin(Chief Operating Officer)in
Veranex provides multi-disciplinary services to medical device and healthcare companies, supporting them from concept through commercialization of medical innovations.
BiotechDigital HealthHealthtechMedical DevicesRaleigh, US
Patrick K. Donnelly(Founder)inMegan Osorio(Chief Executive Officer)inJose Pablo Morales(Chief Medical Officer)inBeth Moeller(Chief Commercial Officer)inDavid Dockhorn(Chief Operating Officer)inManasi Ramanna(Chief Financial Officer)in
Co-investorsSummit PartnersLauxera Capital Partners
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
CartiHealCogentixCogentix MedicalCynerioEDGE Digital RadiographyEndoChoiceGT Medical TechnologiesMCSMomentisNitiloopNLT SpineOISSoniVieTearLabTrukera MedicalValcare
Exits · 5
2 IPOs · 3 acquisitions · showing 3NeuroPaceNASDAQ: NPCESmith+NephewNYSE: SNNMinerva Labsacq. by Rapid7
Portfolio news
latest coverage across their companies
NeuroPace · finance.yahoo.com · Aug 11, 2026
Click Therapeutics · finsmes.com · Apr 9, 2026
Endospan · trysignalbase.com · Mar 25, 2026
Proliferate · ycombinator.com · Feb 23, 2026
IPO stake values · per SEC filings
Value of this firm's stake in each portfolio company at its IPO price, from the prospectus principal-stockholder table.
| Company | Owned | IPO price | At IPO | Stake value |
|---|---|---|---|---|
| NeuroPace | 15.0% | $17.00 | Apr 2021 | $58.7M |
Source: SEC S-1 / 424B prospectus filings. Stake value = shares beneficially owned × the initial public offering price, as disclosed — a market value at IPO, not a return multiple (the firm's original cost is not disclosed).
Frequently asked questions
- How many investments has Accelmed Partners made?
- Accelmed Partners has 52 tracked investments, 5 of which have exited.
- What stage does Accelmed Partners invest at?
- Accelmed Partners invests at the Pre-Seed, Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What sectors does Accelmed Partners focus on?
- Accelmed Partners focuses on Biotech, Digital Health, Healthtech, Medical Devices, SaaS.
- Where is Accelmed Partners located?
- Accelmed Partners is headquartered in Miami, US.
- Who does Accelmed Partners co-invest with?
- Accelmed Partners most often shares deals with Peregrine Ventures, Incentive, Peregrine Ventures Incubator, aMoon, among 79 tracked co-investors.
Similar investors
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Khosla Ventures is a venture capital firm that backs bold, early-stage, technology-driven companies across deep tech and other sectors, providing hands-on 'venture assistance' to help founders build category-defining businesses.
Kleiner Perkins is a venture capital firm that backs founders across technology and life sciences, from early stage through growth.
OCV Partners is a Los Angeles-based venture capital firm founded by former operators that backs companies with differentiated technologies across technology and healthcare markets.